ISRCTN90526229已完成未知
Cypher drug-Eluting stent: a Zwolle Acute myocardial infarction Randomised trial
Isala klinieken (The Netherlands)0 个研究点目标入组 352 人开始时间: 2005年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 352
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with acute myocardial infarction, presenting within six hours after symptom-onset, or those presenting between six and 24 hours if persisting chest pain associated with clinical evidence of on-going ischaemia occurs
- •2. Culprit lesion in a native coronary artery, suitable for stenting
- •3. Lesion length of less than 30 mm, located in a vessel of more than 2.5 mm
- •4. Able to deliver the stent to target lesion (absence of diffuse disease or excessive proximal vessel tortuosity)
- •5. Absence of no-reflow or extensive thrombus throughout vessel
排除标准
- •1. Women of child-bearing potential
- •2. Severe hepatic or renal disease
- •3. Previous participation in the study
- •4. Life expectancy of less than one year
- •5. Factors making follow-up difficult
- •6. Acute myocardial infarction pre-treated with thrombolysis
- •7. Unprotected left main disease or single remaining vessel
- •8. Target lesion in a bifurcation with a large side-branch
- •9. Known sensitivity to aspirin or coumarin
- •10. Unable to provide informed consent
研究者
相似试验
Unknown
4 期
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)CTRI/2013/05/003692Prof SeungJung Park88
已完成
1 期
Drug-Eluting Stent Study Evaluating a New Technology in Patients with Symptomatic Ischemic Heart Disease due to Coronary Artery BlockageCoronary Artery DiseaseACTRN12611001131943Svelte Medical Systems, Inc.30
已完成
4 期
XIENCE V India: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) India Post-Marketing RegistryCTRI/2008/091/000213Abbott Vascular1,000
已完成
4 期
Drug Eluting Balloon in Acute Myocardial Infarctiomyocardial infarctioncoronary disease10011082NL-OMON35144Academisch Medisch Centrum200
进行中（未招募）
不适用
Second Generation? Drug-Eluting Stents Implantation followed by Six versus Twelve-Month - Dual Antiplatelet Therapy - SECURITYEUCTR2008-007526-19-ITFONDAZIONE EVIDENCE4,000